Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment for advanced tumors: SRC reclaims center stage.

Literature DB >> 16533761

Treatment for advanced tumors: SRC reclaims center stage.

Justin M Summy¹, Gary E Gallick.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2006 PMID： 16533761 DOI： 10.1158/1078-0432.CCR-05-2692

Source DB: PubMed Journal: Clin Cancer Res ISSN： 1078-0432 Impact factor: 12.531

Keyword Cloud
Cited

× No keyword cloud information.

75 in total

1. Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer.

Authors: Gary E Gallick; Paul G Corn; Amado J Zurita; Sue-Hwa Lin
Journal: Future Med Chem Date: 2012-01 Impact factor: 3.808

Review 2. Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Authors: Okkyung Rho; Dae Joon Kim; Karou Kiguchi; John Digiovanni
Journal: Mol Carcinog Date: 2010-07-20 Impact factor: 4.784

3. Saracatinib Impairs Head and Neck Squamous Cell Carcinoma Invasion by Disrupting Invadopodia Function.

Authors: Amanda Gatesman Ammer; Laura C Kelley; Karen E Hayes; Jason V Evans; Lesly Ann Lopez-Skinner; Karen H Martin; Barbara Frederick; Brian L Rothschild; David Raben; Paul Elvin; Tim P Green; Scott A Weed
Journal: J Cancer Sci Ther Date: 2009-11-30

4. Significance of ER-Src axis in hormonal therapy resistance.

Authors: Sreeram Vallabhaneni; Binoj C Nair; Valerie Cortez; Rambabu Challa; Dimple Chakravarty; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal: Breast Cancer Res Treat Date: 2010-12-24 Impact factor: 4.872

Review 5. Nonreceptor tyrosine kinases in prostate cancer.

Authors: Yu-Ming Chang; Hsing-Jien Kung; Christopher P Evans
Journal: Neoplasia Date: 2007-02 Impact factor: 5.715

6. Src tyrosine kinase regulates adhesion and chemotaxis in Waldenstrom macroglobulinemia.

Authors: Hai T Ngo; Abdel Kareem Azab; Mena Farag; Xiaoying Jia; Molly M Melhem; Judith Runnels; Aldo M Roccaro; Feda Azab; Antonio Sacco; Xavier Leleu; Kenneth C Anderson; Irene M Ghobrial
Journal: Clin Cancer Res Date: 2009-09-15 Impact factor: 12.531

7. Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?

Authors: Teresa Troiani; Erika Martinelli; Floriana Morgillo; Anna Capasso; Anna Nappi; Vincenzo Sforza; Fortunato Ciardiello
Journal: Ther Adv Med Oncol Date: 2013-01 Impact factor: 8.168